DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Wednesday 2 March 2016

Shahar Keinan, Chief Scientific Officer and Cofounder at Cloud Pharmaceuticals

Shahar Keinan

Shahar Keinan

Chief Scientific Officer and Cofounder at Cloud Pharmaceuticals

Background

Dr. Shahar Keinan, Ph.D., co-founded Cloud Pharmaceuticals, Inc., in 2009 and serves as its Chief Scientific Officer. Dr. Keinan has extensive experience in the field of computational and theoretical chemistry. She has been instrumental in the development of the novel Inverse Design technology since its inception at Duke University, and has pioneered the use of the Inverse Design algorithm to optimize electro-optical materials and protein inhibitors. She has published over 25 peer-reviewed research articles. She leads the development and deployment of Inverse Design and Protein Symphony. She oversees the technical staff of TeraDiscoveries. She serves as Director of Cloud Pharmaceuticals. She obtained a Ph.D. in theoretical chemistry and a B.S. in Chemistry from The Hebrew University of Jerusalem.
LINKS
http://www.cloudpharmaceuticals.com/dr-shahar-keinan.html
https://www.linkedin.com/in/shahar-keinan-9b729b1
https://www.facebook.com/shahar.keinan.5/about
 https://plus.google.com/104847823339870075169/about

Dr. Shahar Keinan

Picture
Shahar Keinan, Ph. D.
Chief Scientific Officer (CSO) and CofounderShahar Keinan is the Chief Scientific Officer and co-founder of Cloud Pharmaceuticals. She has over 20 years of extensive experience in the field of computational and theoretical chemistry. Shahar has received a Ph.D. in theoretical chemistry from The Hebrew University of Jerusalem and has numerous papers and presentations in the fields of in-silico drug design and discovery, as well as molecular materials design and computational methods development.Shahar has been instrumental in the development of the novel Quantum Molecular Design process since its inception at Duke University, and has pioneered the use of the Quantum Molecular Design algorithm to optimize electro-optical materials and protein inhibitors. Currently, she leads the development and deployment of Quantum Molecular Design and oversees the technical staff of Cloud Pharmaceuticals.esign and computational methods development.
Shahar has been instrumental in the development of the novel Quantum Molecular Design process since its inception at Duke University, and has pioneered the use of the Quantum Molecular Design algorithm to optimize electro-optical materials and protein inhibitors. Currently, she leads the development and deployment of Quantum Molecular Design and oversees the technical staff of Cloud Pharmaceuticals.

Experience



Chief Scientific Officer and Cofounder

Cloud Pharmaceuticals
January 2008 – Present (8 years 3 months)RTP, NC
Cloud Pharmaceuticals (previously TeraDiscoveries, Inc.) designs new drugs and drug candidates and accelerates the development process by implementing new, innovative cloud computing technology in place of traditional methods.
Cloud Pharmaceuticals
Cloud Pharmaceuticals


Post-Doctoral fellow

Duke University
January 2004 – September 2011 (7 years 9 months)
Inter-protein electron transfer
Inverse design of NLO materials
Inverse design of drugs
With Prof. Weitao Yang and Prof. David N. Beratan
Preformed theoretical design of organic molecules with high non-linear optical response (hyperpolarizability) properties, using inverse design methodologies.
Designed quinoid inhibitors for Cdc25 phosphatase, with potential as cancer drugs.


Post-Doctoral Fellow

Northwestern University
2001 – 2004 (3 years)Evanston, IL
Design of NLO materials
Theoretical Chemistry group
With Prof. Mark Ratner
Collaborating with the experimental group of Prof. Tobin Marks
Department of Chemistry

Education



The Hebrew University

PhD, Chemistry
1994 – 2000
Advisor: Prof. David Avnir
Thesis title: “The Applications of the Continuous Symmetry and Chirality Measures”

 

Honors & Awards

2002 The Junior Researcher Award from the Lise-Meitner Minerva Center, Israel.
2001 The R. Levine Prize of the Israeli Chemical Society for outstanding chemistry graduate.
1994 The Kenet Prize for Educational Merit in Undergraduate studies.

Shahar Keinan, PhD, Postdoc 2004-2011
CEO and founder Cloud Pharmaceuticals Compan

CSO Shahar Keinan and BOD Lex Van Der Ploeg at Look for at these events
//////